Cytos Biotechnology, based on Zurich, Switzerland announced their results from a large-scale clinical trial for their new antibody formula to help people quit smoking by preventing nicotine from reaching the brain. This new vaccine could be a boon for the millions of people who say they want to quit smoking but have thus far been unable too.
WebProWorld
Headline
Tag: antibodies
Back To Top